Vir Biotechnology Inc
NASDAQ:VIR
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
6.74
12.66
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Vir Biotechnology Inc
Wall Street
Price Targets
VIR Price Targets Summary
Vir Biotechnology Inc
According to Wall Street analysts, the average 1-year price target for
VIR
is 30.09 USD
with a low forecast of 10.1 USD and a high forecast of 115.5 USD.
VIR Last Price Targets
Vir Biotechnology Inc
The latest public price target was made on Aug 2, 2024 by
Gena Wang
from
Barclays
,
who expects
VIR
stock to
rise by 293%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Gena Wang
Barclays
|
28
USD
Upside 293% |
3 months ago
Aug 2, 2024
|
Vir Biotechnology price target raised to $28 from $27 at Barclays
TheFly
|
Michael Ulz
Morgan Stanley
|
15
USD
Upside 111% |
5 months ago
Jun 5, 2024
|
Vir Biotechnology (VIR) PT Raised to $15 at Morgan Stanley
StreetInsider
|
|
Gena Wang
Barclays
|
27
USD
Upside 279% |
6 months ago
May 21, 2024
|
Barclays Reiterates Overweight Rating on Vir Biotechnology (VIR)
StreetInsider
|
Paul Choi
Goldman Sachs
|
28.38
USD
Upside 299% |
1 year ago
Feb 21, 2023
|
DraftKings To Rally Around 38%? Here Are 10 Other Analyst Forecasts For Tuesday
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is VIR's stock price target?
Price Target
30.09
USD
According to Wall Street analysts, the average 1-year price target for
VIR
is 30.09 USD
with a low forecast of 10.1 USD and a high forecast of 115.5 USD.
What is Vir Biotechnology Inc's Revenue forecast?
Projected CAGR
-17%
For the last 5 years the
compound annual growth rate for
Vir Biotechnology Inc's revenue is
52%.
The projected
CAGR
for the next 3 years is
-17%.
You don't have any saved screeners yet
